clobetasol propionate + salicylic acid

The drug clobetasol propionate + salicylic acid is a topical combination medication primarily used to treat skin conditions such as eczema and psoriasis. This combination leverages the anti-inflammatory properties of clobetasol propionate (a high-potency corticosteroid) with the keratolytic effects of salicylic acid. ## Composition and Formulation Clobetasol propionate + salicylic acid typically contains 0.05% clobetasol propionate and 6% salicylic acid[1][5]. It's available in various formulations including: - Lotion - Ointment - Cream ## Mechanism of Action This combination works through complementary mechanisms: - **Clobetasol Propionate**: A high-potency corticosteroid that blocks the production of chemical messengers (prostaglandins) responsible for inflammation. It reduces redness, swelling, and itching by stabilizing leukocyte lysosomal membranes, inhibiting macrophage accumulation, reducing leukocyte adhesion to capillary endothelium, decreasing capillary wall permeability, and antagonizing histamine activity[5][6]. - **Salicylic Acid**: A keratolytic agent that softens, separates, and causes desquamation (peeling) of the cornified epithelium or horny layer of skin. It breaks down keratin clumps, removes dead skin cells, and helps soften the skin. Additionally, it enhances the absorption of clobetasol into the skin and possesses mild antiseptic properties[2][5]. ## Therapeutic Uses The combination is primarily indicated for: - Psoriasis (including plaque psoriasis) - Eczema (including nummular eczema, hand eczema, eczematous dermatitis) - Chronic atopic dermatitis - Neurodermatitis (lichen simplex chronicus) - Lichen planus - Seborrheic dermatitis of the scalp - Ichthyosis vulgaris and other ichthyotic conditions - Other hyperkeratotic and dry corticosteroid-responsive dermatoses[5][6] ## Administration The medication should be used as prescribed by healthcare providers. General guidelines include: - Apply a thin layer to the affected area - Use only for the prescribed duration - For external use only - Wash hands before and after application - Avoid covering treated areas with bandages unless directed by a healthcare provider[2][6] ## Side Effects Common side effects may include: - Skin reactions (burning, stinging, itching, irritation) - Thinning of the skin - Peeling of the skin - Redness at the application site - With prolonged use: increased hair growth, weakening of skin[2][6] ## Precautions - Not recommended for diaper rash - Should not be used in the presence of allergic reactions to any components - Caution advised for patients with kidney or liver issues - Not to be discontinued without consulting a healthcare provider - Long-term use may cause skin thinning and other adverse effects[3][6] ## Development Status A new formulation combining clobetasol propionate, salicylic acid, tretinoin, and urea (GN-037) is currently in Phase II clinical trials for the treatment of mild to moderate plaque psoriasis, being developed by Gen Ilac ve Saglik Urunleri[7]. This combination medication represents an effective approach to treating inflammatory skin conditions by simultaneously addressing inflammation and hyperkeratosis (thickening of the skin).

Brand names

Medisalic

Other names

clobetasol propionate + salicylic acid